Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: Comparison of the suction blister technique and cutaneous microdialysis

Acta Dermato-Venereologica

Volumn 79, Issue 4, 1999, Pages 274-277

  Borg, Natalia ^a   Götharson, Eva ^a   Benfeldt, Eva ^c   Groth, Lotte ^b   Ståhle, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LEO PHARMA A S   (Denmark)

^c NONE

Author keywords

Dermal drug concentration; Famciclovir; Microdialysis; Temperature; Vasoconstriction

Indexed keywords

ADRENALIN; FAMCICLOVIR; PENCICLOVIR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; HERPES VIRUS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MICRODIALYSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN; SUCTION; TEMPERATURE SENSITIVITY; VASOCONSTRICTION; VOLUNTEER;

2-AMINOPURINE; ACYCLOVIR; ADMINISTRATION, ORAL; ADULT; ANTIVIRAL AGENTS; BLISTER; DIALYSIS SOLUTIONS; EPINEPHRINE; FEMALE; HUMANS; MALE; MICRODIALYSIS; PRODRUGS; SKIN; TEMPERATURE; TIME FACTORS; TISSUE DISTRIBUTION; VASOCONSTRICTOR AGENTS;

EID: 0032968027     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750010643     Document Type: Article

References (12)

1. 1. Crumpacker C. The pharmacological profile of famciclovir. Semin Dermatol 1996; 15 Suppl 1: 14-26.
2. 2. Pue MA, Pratt SK, Fairless AJ, Laroche J, Georgiou P, Prince W. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. J Antimicrob Chemother 1994; 33: 119-127.
3. 3. Luber AD, Flaherty JF Jr. Famciclovir for treatment of herpesvirus infections. Ann Pharmacother 1996; 30: 978-985.
4. 4. Surber C. Drug concentration in the skin. In: Maibach H, editor. Dermatologic Research Techniques. Boca Raton: CRC Press, 1996; 151-178.
5. 5. Groth L. Cutaneous microdialysis: methodology and validation. Acta Derm Venereol (Stockh) 1996; Suppl 197.
6. 6. Benfeldt E, Groth L. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 1998; 78: 274-278.
7. 7. Cross SE, Anderson C, Roberts MS. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Brit J Clin Pharmacol 1998; 46: 29-35.
8. 8. Borg N, Ståhle L. Penciclovir: pharmacokinetics and distribution to the brain and muscle in the rat, studied by microdialysis. Antivir Chem Chemother 1997; 8: 275-279.
9. 9. Svensson JO, Barkholt L, Säwe J. Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography. J Chromatography 1997; 690: 363-366.
10. 10. Ståhle L. Zero and first moment area estimation from microdialysis data. Eur J Clin Pharmacol 1993; 45: 477-481.
11. 11. Jacobson I, Sandberg M, Hambeger A. Mass transfer in brain dialysis devices-a new method for the estimation of extracellular amino acids concentration. J Neurosci Methods 1985; 15: 263-268.
12. 12. Singh P, Roberts MS. Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J Pharm Sci 1994; 83: 783-791.